pindolol has been researched along with Myocarditis in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recovery from viral myocarditis is usually excellent and complete although it occasionally results in sudden death during its acute stage." | 1.29 | Myocardial beta-receptor and cardiac angiotensin alterations during the acute and chronic phases of viral myocarditis. ( Adachi, H; Kanda, T; Murata, K; Ohno, T; Suzuki, T, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanda, T | 1 |
| Adachi, H | 1 |
| Ohno, T | 1 |
| Suzuki, T | 1 |
| Murata, K | 1 |
1 other study available for pindolol and Myocarditis
| Article | Year |
|---|---|
Myocardial beta-receptor and cardiac angiotensin alterations during the acute and chronic phases of viral myocarditis.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiovirus Infections; Down-Regulation; Encephalomyocarditi | 1994 |